medicines


EDITORIAL: Health at stake in free-trade talks
For the United States, intellectual property rights represent the single most valuable asset in light of the new reality of information-based economies and where they derive their national wealth. The supremacy of the US as a global power depends on how effective it is in acquiring and maintaining its ownership of knowledge assets.
Draft amendment to patent law a 'sell-out'
Opponents of a free trade area (FTA) agreement with the US have lashed out at the government's proposed amendment of Thai patent law to facilitate the United States' patenting of drugs and living organisms in Thailand. They fear it would lead to greater control of the country's resources by American firms.
Myths and realities: The impact of the US-Thai FTA on access to medicines
Reeling from the negative publicity and pro-access to medicines messaging in Thailand and internationally, the Office of the US Trade Representative (USTR) has mounted a public relations campaign full of distortions and omissions.
Free trade with US will hurt health care
Will the hands that save the lives of Thailand's sick be tied once a free trade deal between this country and the United States is signed, later this year?
US-Thailand FTA - IPR text proposed by US (2006)
US proposal on 'patents' and on 'measures related to certain regulated products' for negotiation with Thailand under the IPR chapter of the current US-Thailand FTA talks.
IP standards in US-Peru FTA to affect talks with Colombia and Ecuador?
Critics argue that the biodiversity provisions in the US-Peru FTA do not improve the status quo to effectively tackle concerns over misappropriation of biodiversity and TK.
Ecuador-Colomb-US resume FTA talks
Ecuador, along with Colombia, is reopening Wednesday in Washington joint negotiation over the copyright issue in the Free Trade Agreement with the US, despite growing refusal in Quito.
Sacrificing lives for patents under FTA
On the last day of the sixth round of Thai-US Free Trade Area talks, several academics and non-governmental bodies were invited to discuss their concerns with US negotiators on aspects of intellectual property rights, with an emphasis on pharmaceutical and life form patents. For a number of reasons, only one academic showed up.
Civil society network resumes opposition to Thai-US FTA pact
The network of 11 civil society organisations which showed its opposition to the Thai-US Free Trade Area (FTA) negotiations earlier this week in Chiang Mai Friday reaffirmed its intention to continue protesting the talks.
Thai-US FTA talks: Stumbling block
The Thai-US free-trade talks hit a snag yesterday after the head Thai negotiator for intellectual-property rights declared demands by the US for Thailand to tighten up drug patenting as “unacceptable”.